6Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial treatment of infections a risk factor for hosp italmortality among critically ill patients [J]. Chest, 1999, 115 (2) : 462-474.
7Craig WA. Pharmacokinetic /Pharmacodynamic parameters: rationale for antibacterial dosing of mice and men [J]. Clin Infect Dis, 1998, 2 (1): 1-10.
8Zhanel GG. Influence of pharmaeokinetic and pharmacodynamic princi- ple on antibiotics selection [J]. Curr Infect Dis Rep, 2001, 3 (1): 29 - 34.
9Workman P. How much gets there and what does it do? The need for better pharmacokinetic and pharmacodynamic endpoints in contemporary drug discovery and development [ J ]. Curr Pharm Design, 2003, 9 (11) : 891 -902.
